Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lubrano

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Brain & Spine|November 29, 2023
European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapyFlorian Scheichel, Branko Popadic, Daniel Pinggera, et al.
Journal of Neuro-Oncology|July 20, 2015
Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combinationSoléakhéna Ken, Alexandra Deviers, Thomas Filleron, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2017
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised studyRenata Ursu, Alexandre Carpentier, Philippe Metellus, et al.
Oncotarget|October 19, 2018
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastomaSabrina Boyrie, Caroline Delmas, Anthony Lemarié, et al.
Science Advances|November 3, 2023
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cellsAnthony Lemarié, Vincent Lubrano, Caroline Delmas, et al.
Radiation Oncology (London, England)|January 3, 2013
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boostSoléakhéna Ken, Laure Vieillevigne, Xavier Franceries, et al.
Magnetic Resonance in Medicine|November 26, 2021
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2023
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Acta Neuropathologica Communications|November 29, 2025
Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiationPerrine Dahan, Tom Maillet, Laure Malric, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastomaAnne Ducassou, Emmanuelle Uro-Coste, Pierre Verrelle, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Brain & Spine|November 29, 2023
European survey on neurosurgical management of primary central nervous system lymphomas and preoperative corticosteroid therapyFlorian Scheichel, Branko Popadic, Daniel Pinggera, et al.
Journal of Neuro-Oncology|July 20, 2015
Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combinationSoléakhéna Ken, Alexandra Deviers, Thomas Filleron, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2017
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised studyRenata Ursu, Alexandre Carpentier, Philippe Metellus, et al.
Oncotarget|October 19, 2018
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastomaSabrina Boyrie, Caroline Delmas, Anthony Lemarié, et al.
Science Advances|November 3, 2023
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cellsAnthony Lemarié, Vincent Lubrano, Caroline Delmas, et al.
Radiation Oncology (London, England)|January 3, 2013
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boostSoléakhéna Ken, Laure Vieillevigne, Xavier Franceries, et al.
Magnetic Resonance in Medicine|November 26, 2021
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2023
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Acta Neuropathologica Communications|November 29, 2025
Early metabolic reprogramming and carbonic anhydrase IX-mediated extracellular acidification drive radiotherapy-induced glioblastoma cell dedifferentiationPerrine Dahan, Tom Maillet, Laure Malric, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2013
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastomaAnne Ducassou, Emmanuelle Uro-Coste, Pierre Verrelle, et al.
Pageof 4